Insight into yeast: A study model of lipid metabolism and terpenoid biosynthesis

With the development of transcriptomics, metabolomics, proteomics, and mathematical modeling, yeast Saccharomyces cerevisiae is recently considered as a model studying strain by biologists who try to reveal the mystery of microorganic metabolism or develop heterologous pharmaceutical and economic products. Among S. cerevisiae metabolic research, lipid metabolism always attracts great interest because of its dominant role in cell physiology. Related researchers have developed multiple functions from cell membrane component such as adjustment to changing environment and impact on protein folding. Nowadays, many common human diseases such as diabetes mellitus, Alzheimer's disease, obesity, and atherosclerosis are related to lipid metabolism, which makes the study of lipids a desperate need. In addition to lipid metabolism, the study of the native mevalonic acid (MVA) pathway in S. cerevisiae has increased exponentially because of its huge potential to produce economically important products terpenoids. With the progress of technology in gene engineering and metabolic engineering, more and more biosynthetic pathways will be developed and put into industrial application.

[1]  Xueli Zhang,et al.  Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. , 2013, Metabolic engineering.

[2]  J. Thevelein,et al.  Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro. , 2013, The New phytologist.

[3]  S. Zhao,et al.  Heterologous expression of dammarenediol synthase gene in an engineered Saccharomyces cerevisiae , 2012, Letters in applied microbiology.

[4]  M. L. Greenberg,et al.  Lipidomics of intact mitochondria by MALDI-TOF/MS[S] , 2012, Journal of Lipid Research.

[5]  J. Keasling Synthetic biology and the development of tools for metabolic engineering. , 2012, Metabolic engineering.

[6]  Wei Gao,et al.  Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production. , 2012, Journal of the American Chemical Society.

[7]  S. Henry,et al.  Metabolism and Regulation of Glycerolipids in the Yeast Saccharomyces cerevisiae , 2012, Genetics.

[8]  G. Yan,et al.  Enhancement of β-Carotene Production by Over-Expression of HMG-CoA Reductase Coupled with Addition of Ergosterol Biosynthesis Inhibitors in Recombinant Saccharomyces cerevisiae , 2012, Current Microbiology.

[9]  Kazuki Saito,et al.  CYP716A subfamily members are multifunctional oxidases in triterpenoid biosynthesis. , 2011, Plant & cell physiology.

[10]  Kai Simons,et al.  Cell membranes: the lipid perspective. , 2011, Structure.

[11]  S. Moineau,et al.  Bacteriophages of lactic acid bacteria and their impact on milk fermentations , 2011, Microbial cell factories.

[12]  G. Carman,et al.  Regulation of phospholipid synthesis in the yeast Saccharomyces cerevisiae. , 2011, Annual review of biochemistry.

[13]  Chandra L. Theesfeld,et al.  The Sterol-sensing Domain (SSD) Directly Mediates Signal-regulated Endoplasmic Reticulum-associated Degradation (ERAD) of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Isozyme Hmg2* , 2011, The Journal of Biological Chemistry.

[14]  Lee H. Dicker,et al.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity , 2011, Nature.

[15]  Jens Nielsen,et al.  Diversion of Flux toward Sesquiterpene Production in Saccharomyces cerevisiae by Fusion of Host and Heterologous Enzymes , 2010, Applied and Environmental Microbiology.

[16]  J. Keasling Manufacturing Molecules Through Metabolic Engineering , 2010, Science.

[17]  Alexandre P. Blanchard,et al.  Lipidomics era: accomplishments and challenges. , 2010, Mass spectrometry reviews.

[18]  C. A. Masuda,et al.  A New Fluorescence-Based Method Identifies Protein Phosphatases Regulating Lipid Droplet Metabolism , 2010, PloS one.

[19]  Barry P. Young,et al.  Phosphatidic Acid Is a pH Biosensor That Links Membrane Biogenesis to Metabolism , 2010, Science.

[20]  Kelly M. Thayer,et al.  Combining metabolic and protein engineering of a terpenoid biosynthetic pathway for overproduction and selectivity control , 2010, Proceedings of the National Academy of Sciences.

[21]  L. Daviet,et al.  Biotechnology in plant essential oil production: progress and perspective in metabolic engineering of the terpene pathway , 2010 .

[22]  R. Hampton,et al.  Geranylgeranyl Pyrophosphate Is a Potent Regulator of HRD-dependent 3-Hydroxy-3-methylglutaryl-CoA Reductase Degradation in Yeast* , 2009, The Journal of Biological Chemistry.

[23]  S. Jennewein,et al.  Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. , 2008, Metabolic engineering.

[24]  J. Keasling,et al.  Engineering triterpene production in Saccharomyces cerevisiae–β‐amyrin synthase from Artemisia annua , 2008, The FEBS journal.

[25]  D. Ramón,et al.  Engineering the Saccharomyces cerevisiae isoprenoid pathway for de novo production of aromatic monoterpenes in wine. , 2008, Metabolic engineering.

[26]  Jens Nielsen,et al.  Production of plant sesquiterpenes in Saccharomyces cerevisiae: Effect of ERG9 repression on sesquiterpene biosynthesis , 2008, Biotechnology and bioengineering.

[27]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[28]  S. Henry,et al.  Phosphatidic Acid Plays a Central Role in the Transcriptional Regulation of Glycerophospholipid Synthesis in Saccharomyces cerevisiae* , 2007, Journal of Biological Chemistry.

[29]  R. Murphy,et al.  Lysophosphatidylcholine Metabolism in Saccharomyces cerevisiae , 2007, Journal of Biological Chemistry.

[30]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[31]  Shunji Takahashi,et al.  Metabolic engineering of sesquiterpene metabolism in yeast , 2007, Biotechnology and bioengineering.

[32]  J. Lopes,et al.  Genomic Analysis of the Opi− Phenotype , 2006, Genetics.

[33]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[34]  Thomas E. Ferrin,et al.  Designed divergent evolution of enzyme function , 2006, Nature.

[35]  Hannes Grabner,et al.  A genome-wide visual screen reveals a role for sphingolipids and ergosterol in cell surface delivery in yeast. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Kimata,et al.  Yeast unfolded protein response pathway regulates expression of genes for anti‐oxidative stress and for cell surface proteins , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[37]  S. Oliaro-Bosso,et al.  Characterizing Sterol Defect Suppressors Uncovers a Novel Transcriptional Signaling Pathway Regulating Zymosterol Biosynthesis* , 2005, Journal of Biological Chemistry.

[38]  R. Verpoorte,et al.  The Catharanthus alkaloids: pharmacognosy and biotechnology. , 2004, Current medicinal chemistry.

[39]  Jasper Rine,et al.  Upc2p and Ecm22p, Dual Regulators of Sterol Biosynthesis in Saccharomyces cerevisiae , 2001, Molecular and Cellular Biology.

[40]  Peter Walter,et al.  Functional and Genomic Analyses Reveal an Essential Coordination between the Unfolded Protein Response and ER-Associated Degradation , 2000, Cell.

[41]  D. Kelly,et al.  Systematic analysis of yeast strains with possible defects in lipid metabolism , 1999, Yeast.

[42]  U. Stahl,et al.  Enhanced sterol-acyl transferase activity promotes sterol accumulation in Saccharomyces cerevisiae , 1999, Applied Microbiology and Biotechnology.

[43]  M. Bard,et al.  Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae , 1998, Yeast.

[44]  R. Hampton,et al.  Effects of overproduction of the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae , 1997, Applied and environmental microbiology.

[45]  W. Hampel,et al.  Influence of growth rate on the accumulation of ergosterol in yeast-cells , 1990, Biotechnology Letters.

[46]  Sean R. Collins,et al.  Supporting Online Material : Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum , 2009 .

[47]  W. Abplanalp,et al.  Ergosterol (major sterol of baker's and brewer's yeast extracts) inhibits the growth of human breast cancer cells in vitro and the potential role of its oxidation products. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[48]  W. Dowhan,et al.  Molecular basis for membrane phospholipid diversity: why are there so many lipids? , 1997, Annual review of biochemistry.